Cocrystal Pharma, Inc. (NASDAQ: COCP) is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of COVID-19 and other coronaviruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs.
The company is enrolling subjects in a Phase 1 trial with an antiviral candidate for pandemic and seasonal influenza A, and plans to initiate COVID-19 clinical trials in 2022 with an orally administered and inhalation/pulmonary delivered antiviral candidates.
Company Details
- Employees
- 14
- Address
- 19805 N. Creek Parkway, Bothell,washington 98011,united States
- Phone
- 833-475-8247
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cocrystalpharma.com
- Keywords
- antiviral therapeutics, small molecule therapeutics, chronic viral diseases, biotechnology, replication enzymes.
- HQ
- Bothell, Washington
Cocrystal Pharma, Inc. Questions
Cocrystal Pharma, Inc.'s helpline number is 833-475-8247
Cocrystal Pharma, Inc.'s website is http://www.cocrystalpharma.com
Cocrystal Pharma, Inc.'s LinkedIn profile is https://www.linkedin.com/company/cocrystal-pharma-inc-
Cocrystal Pharma, Inc. has
14 employees.
View email and phone details for 14
employees at Cocrystal Pharma, Inc..
Cocrystal Pharma, Inc.'s industry is
Biotechnology Research
Cocrystal Pharma, Inc.'s top competitors are
Immunome, Inc.,
Athira Pharma,
Sound Biologics,
Hdt Bio,
Achieve Life Sciences,
Biolife Solutions, Inc.,
Atossa Therapeutics, Inc.,
Aptevo Therapeutics Inc,
Sana Biotechnology, Inc.,
Mozart Therapeutics, Inc..
Cocrystal Pharma, Inc.'s support email address is info@cocrystalpharma.com
Cocrystal Pharma, Inc.'s categories are Biotechnology Research
